Madrigal Pharmaceuticals Inc (MDGL)
201.07
+7.74
(+4.00%)
USD |
NASDAQ |
Apr 29, 16:00
200.92
-0.15
(-0.07%)
Pre-Market: 20:00
Madrigal Pharmaceuticals Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2012 | 0.4877 |
| December 31, 2011 | 1.125 |
| September 30, 2011 | 0.6821 |
| June 30, 2011 | 0.464 |
| March 31, 2011 | 1.298 |
| December 31, 2010 | 0.4969 |
| September 30, 2010 | 0.5077 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
| December 31, 2009 | 0.00 |
| September 30, 2009 | 0.00 |
| June 30, 2009 | 0.00 |
| March 31, 2009 | -0.1053 |
| December 31, 2008 | 0.00 |
| September 30, 2008 | -0.0696 |
| Date | Value |
|---|---|
| June 30, 2008 | -0.252 |
| March 31, 2008 | 0.2239 |
| December 31, 2007 | 0.0966 |
| September 30, 2007 | 0.0632 |
| June 30, 2007 | 0.0465 |
| March 31, 2007 | 0.0352 |
| December 31, 2006 | -1.334 |
| September 30, 2006 | 0.2192 |
| June 30, 2006 | |
| March 31, 2006 | |
| December 31, 2005 | 0.0365 |
| September 30, 2005 | |
| June 30, 2005 | |
| March 31, 2005 | 0.0074 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly and Co | 2.342 |
| Viking Therapeutics Inc | -- |
| Akero Therapeutics Inc | -- |
| 89bio Inc | -- |
| Geron Corp | 0.3305 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 640.55M |
| Total Liabilities (Quarterly) | 235.21M |
| Shareholders Equity (Quarterly) | 405.33M |